US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jaguar Animal Health

0.6610

-0.0090-1.34%

Post-market: 0.70000.0390+5.90%19:59 EST

Volume:294.41K

Turnover:195.00K

Market Cap:2.76M

PE:-0.02

High:0.6877

Open:0.6767

Low:0.6300

Close:0.6700

52wk High:25.75

52wk Low:0.5600

Shares:4.18M

Float Shares:2.79M

Volume Ratio:0.62

T/O Rate:10.55%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-34.7371

EPS(LYR):-130.6878

ROE:-411.57%

ROA:-38.01%

PB:0.88

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Jaguar Health Reduces Debt Through Equity Exchange with Iliad

Jaguar Health highlights strategic focus on rare disease development program

Jaguar Health to Present Rare Disease Pipeline at Sequire Investor Summit in Puerto Rico

BRIEF-Jaguar Health Inc - Co & Unit Entered License Agreement With Woodward Specialty Llc - SEC Filing

Jaguar Health Inc - Woodward Specialty to Pay Napo Upfront $18 Mln Including $16 Mln on Effective Date - SEC Filing

THOMSON REUTERS

Jaguar Health Signs $38 Million U.S. Licensing Deal With Future Pak for Crofelemer Products

Jaguar Health to Present Updates at Lytham Partners Healthcare Investor Summit

Jaguar Health Secures $350,000 Unsecured Loan from Accredited Investors

Jaguar Health Signs $38 Million U.S. Licensing Deal with Future Pak for Mytesi and Canalevia-CA1

Jaguar Animal Health Raises Short-Term Capital Through Notes

Jaguar Health Reports Crofelemer Reduces Parenteral Support in Pediatric Intestinal Failure Study

Jaguar Health Secures $240,000 FDA Grant for Canalevia-CA1 Chemotherapy-Induced Diarrhea Study in Dogs

Jaguar Health Announces Preliminary Clinical Trial Results for Crofelemer in Short Bowel Syndrome

Jaguar Health Issues Pre-Funded Warrants in Exchange for Preferred Stock

Jaguar Health Showcases Novel Plant-Based Gastrointestinal Medicines in Latest Corporate Presentation

Jaguar Health Inc. Held Special Meeting of Stockholders

Jaguar Health Seeks EMA Feedback on Canalevia EU Approval for Dog Diarrhea

Jaguar Health Secures Australian Patent for Crofelemer in Treating Short Bowel Syndrome and Related Disorders

Jaguar Health Submits Amended Protocol to FDA for Crofelemer MVID Trial

Jaguar Health Extends $6.2 Million Note and Amends $36 Million Royalty Agreements with Investors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JAGX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"JAGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JAGX\",,,,,undefined,":{"symbol":"JAGX","market":"US","secType":"STK","nameCN":"Jaguar Animal Health","latestPrice":0.661,"timestamp":1770670800000,"preClose":0.67,"halted":0,"volume":294410,"hourTrading":{"tag":"盘后","latestPrice":0.7,"preClose":0.661,"latestTime":"19:59 EST","volume":58267,"amount":40226.73462,"timestamp":1770685173820,"change":0.039,"changeRate":0.059002,"amplitude":0.079728},"delay":0,"changeRate":-0.013432835820895533,"floatShares":2791600,"shares":4175800,"eps":-34.73711,"marketStatus":"Not Yet Opened","change":-0.009,"latestTime":"02-09 16:00:00 EST","open":0.6767,"high":0.6877,"low":0.630001,"amount":195002.66958699998,"amplitude":0.086118,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-34.73711,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1431489600000,"exchange":"NASDAQ","adjPreClose":0.67,"preHourTrading":{"tag":"盘前","latestPrice":0.64,"preClose":0.67,"latestTime":"09:26 EST","volume":4319,"amount":2837.48210816,"timestamp":1770647166734,"change":-0.03,"changeRate":-0.044776,"amplitude":0.073134},"postHourTrading":{"tag":"盘后","latestPrice":0.7,"preClose":0.661,"latestTime":"19:59 EST","volume":58267,"amount":40226.73462,"timestamp":1770685173820,"change":0.039,"changeRate":0.059002,"amplitude":0.079728},"volumeRatio":0.623701,"impliedVol":3.1923,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JAGX\",,,,,undefined,":{"symbol":"JAGX","floatShares":2791600,"roa":"-38.01%","roe":"-411.57%","lyrEps":-130.687798,"volumeRatio":0.623701,"shares":4175800,"dividePrice":0,"high":0.6877,"amplitude":0.086118,"preClose":0.67,"low":0.630001,"week52Low":0.56,"pbRate":"0.88","psRate":"0.23","week52High":25.75,"institutionHeld":0,"latestPrice":0.661,"eps":-34.73711,"divideRate":0,"volume":294410,"delay":0,"ttmEps":-34.73711,"open":0.6767,"prevYearClose":0.9312,"prevWeekClose":0.67,"prevMonthClose":0.6746,"prevQuarterClose":0.9312,"fiveDayClose":0.6401,"twentyDayClose":1.05,"sixtyDayClose":1.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JAGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"JAGX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-08-14","symbol":"JAGX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-10.26},{"market":"US","date":"2025-05-15","symbol":"JAGX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-16.7},{"date":"2025-03-31","symbol":"JAGX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743408000000,"name":null,"time":"Pre-Market","dateTimestamp":1743393600000,"actualEps":null},{"market":"US","date":"2025-03-24","symbol":"JAGX","defaultRemindTime":1742823000000,"type":"split","dateTimestamp":1742788800000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JAGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JAGX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1721624400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JAGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JAGX","date":"2026-02-06","current":-0.019029,"percent":0.981163,"low":-11.785749,"twenty":-1.108153,"median":-0.309258,"eighty":-0.12748,"high":-0.028845,"avg":-1.133579,"sd":2.028665,"marketCap":2687329},"quantilePoints":[{"date":"2021-02-12","current":-10.666849,"twenty":-9.422204,"median":-0.485088,"eighty":-0.24708,"marketCap":330661652},{"date":"2021-02-19","current":-10.666849,"twenty":-9.623456,"median":-0.487407,"eighty":-0.247137,"marketCap":330661652},{"date":"2021-02-26","current":-7.832302,"twenty":-9.623456,"median":-0.491454,"eighty":-0.247151,"marketCap":242793520},{"date":"2021-03-05","current":-5.967468,"twenty":-9.531978,"median":-0.495172,"eighty":-0.247151,"marketCap":184985539},{"date":"2021-03-12","current":-8.093378,"twenty":-9.4405,"median":-0.500575,"eighty":-0.247458,"marketCap":250886638},{"date":"2021-03-19","current":-7.981488,"twenty":-9.422204,"median":-0.503246,"eighty":-0.247617,"marketCap":247418159},{"date":"2021-03-26","current":-6.862588,"twenty":-9.389717,"median":-0.508595,"eighty":-0.247637,"marketCap":212733370},{"date":"2021-04-01","current":-7.499614,"twenty":-9.351074,"median":-0.510386,"eighty":-0.247637,"marketCap":253554439},{"date":"2021-04-09","current":-7.007215,"twenty":-9.330727,"median":-0.515888,"eighty":-0.247783,"marketCap":236906925},{"date":"2021-04-16","current":-4.923989,"twenty":-9.330727,"median":-0.51778,"eighty":-0.247948,"marketCap":166475136},{"date":"2021-04-23","current":-6.136048,"twenty":-9.27584,"median":-0.52826,"eighty":-0.248274,"marketCap":207453631},{"date":"2021-04-30","current":-6.139838,"twenty":-9.080078,"median":-0.533709,"eighty":-0.249318,"marketCap":207581771},{"date":"2021-05-07","current":-5.326614,"twenty":-8.915551,"median":-0.543343,"eighty":-0.25018,"marketCap":180087497},{"date":"2021-05-14","current":-5.163969,"twenty":-8.652829,"median":-0.549163,"eighty":-0.250418,"marketCap":174588642},{"date":"2021-05-21","current":-4.826414,"twenty":-8.436508,"median":-0.552518,"eighty":-0.251373,"marketCap":182834231},{"date":"2021-05-28","current":-5.806213,"twenty":-8.30224,"median":-0.554602,"eighty":-0.252339,"marketCap":219950955},{"date":"2021-06-04","current":-6.423123,"twenty":-8.197809,"median":-0.556669,"eighty":-0.252571,"marketCap":243320744},{"date":"2021-06-11","current":-6.931167,"twenty":-8.115756,"median":-0.562359,"eighty":-0.252651,"marketCap":262566452},{"date":"2021-06-18","current":-5.87879,"twenty":-8.093378,"median":-0.56269,"eighty":-0.25282,"marketCap":222700341},{"date":"2021-06-25","current":-6.314256,"twenty":-8.07846,"median":-0.566712,"eighty":-0.25313,"marketCap":239196663},{"date":"2021-07-02","current":-5.515902,"twenty":-8.052942,"median":-0.572161,"eighty":-0.253557,"marketCap":208953407},{"date":"2021-07-09","current":-5.987657,"twenty":-8.042343,"median":-0.576292,"eighty":-0.25377,"marketCap":226824422},{"date":"2021-07-16","current":-4.753837,"twenty":-8.011326,"median":-0.582908,"eighty":-0.254192,"marketCap":180084844},{"date":"2021-07-23","current":-5.443325,"twenty":-7.974641,"median":-0.592347,"eighty":-0.254244,"marketCap":206204020},{"date":"2021-07-30","current":-5.080436,"twenty":-7.946642,"median":-0.601083,"eighty":-0.254357,"marketCap":192457085},{"date":"2021-08-06","current":-4.935281,"twenty":-7.921814,"median":-0.604375,"eighty":-0.254391,"marketCap":186958311},{"date":"2021-08-13","current":-3.990062,"twenty":-7.832302,"median":-0.662703,"eighty":-0.25469,"marketCap":170475382},{"date":"2021-08-20","current":-3.636105,"twenty":-7.817383,"median":-0.693062,"eighty":-0.255915,"marketCap":155352566},{"date":"2021-08-27","current":-3.925706,"twenty":-7.757708,"median":-0.72931,"eighty":-0.256055,"marketCap":167725779},{"date":"2021-09-03","current":-3.732638,"twenty":-7.75728,"median":-0.752929,"eighty":-0.256197,"marketCap":159476970},{"date":"2021-09-10","current":-2.788752,"twenty":-7.75557,"median":-0.775055,"eighty":-0.256419,"marketCap":119149448},{"date":"2021-09-17","current":-2.602402,"twenty":-7.720412,"median":-0.90416,"eighty":-0.256579,"marketCap":111187607},{"date":"2021-09-24","current":-2.41883,"twenty":-7.683115,"median":-0.928743,"eighty":-0.256579,"marketCap":103344498},{"date":"2021-10-01","current":-2.35404,"twenty":-7.537491,"median":-0.958083,"eighty":-0.256642,"marketCap":100576342},{"date":"2021-10-08","current":-2.246056,"twenty":-7.499614,"median":-0.985302,"eighty":-0.257041,"marketCap":95962749},{"date":"2021-10-15","current":-2.170468,"twenty":-7.462907,"median":-1.05349,"eighty":-0.258062,"marketCap":92733232},{"date":"2021-10-22","current":-1.954501,"twenty":-7.461737,"median":-1.08173,"eighty":-0.258893,"marketCap":83506045},{"date":"2021-10-29","current":-2.300048,"twenty":-7.348106,"median":-1.089845,"eighty":-0.258893,"marketCap":98269545},{"date":"2021-11-05","current":-2.192064,"twenty":-7.310148,"median":-1.108338,"eighty":-0.258893,"marketCap":93655951},{"date":"2021-11-12","current":-2.040888,"twenty":-7.24341,"median":-1.129467,"eighty":-0.259157,"marketCap":87196920},{"date":"2021-11-19","current":-1.480806,"twenty":-7.082968,"median":-1.140096,"eighty":-0.25916,"marketCap":69673418},{"date":"2021-11-26","current":-1.35332,"twenty":-7.04555,"median":-1.14541,"eighty":-0.260478,"marketCap":63675044},{"date":"2021-12-03","current":-1.157186,"twenty":-7.016659,"median":-1.154482,"eighty":-0.260807,"marketCap":54446777},{"date":"2021-12-10","current":-1.255253,"twenty":-7.008127,"median":-1.159256,"eighty":-0.261077,"marketCap":59060911},{"date":"2021-12-17","current":-1.108153,"twenty":-6.981025,"median":-1.154482,"eighty":-0.261483,"marketCap":52139710},{"date":"2021-12-23","current":-1.137573,"twenty":-6.948491,"median":-1.154482,"eighty":-0.261962,"marketCap":53523950},{"date":"2021-12-31","current":-1.019893,"twenty":-6.931167,"median":-1.14651,"eighty":-0.262386,"marketCap":47986990},{"date":"2022-01-07","current":-0.916923,"twenty":-6.89002,"median":-1.141096,"eighty":-0.262547,"marketCap":43142149},{"date":"2022-01-14","current":-0.943891,"twenty":-6.840731,"median":-1.138238,"eighty":-0.262591,"marketCap":44411036},{"date":"2022-01-21","current":-0.7913,"twenty":-6.822828,"median":-1.13352,"eighty":-0.262917,"marketCap":37231444},{"date":"2022-01-28","current":-0.710787,"twenty":-6.805897,"median":-1.127766,"eighty":-0.263488,"marketCap":33443240},{"date":"2022-02-04","current":-0.776877,"twenty":-6.774449,"median":-1.110386,"eighty":-0.263641,"marketCap":36552858},{"date":"2022-02-11","current":-0.695215,"twenty":-6.737851,"median":-1.104056,"eighty":-0.263904,"marketCap":32710584},{"date":"2022-02-18","current":-0.595741,"twenty":-6.691294,"median":-1.094095,"eighty":-0.264818,"marketCap":28030206},{"date":"2022-02-25","current":-0.503143,"twenty":-6.654638,"median":-1.084584,"eighty":-0.265647,"marketCap":23673365},{"date":"2022-03-04","current":-0.455518,"twenty":-6.63757,"median":-1.056898,"eighty":-0.265747,"marketCap":21432595},{"date":"2022-03-11","current":-0.571741,"twenty":-6.620456,"median":-1.049313,"eighty":-0.266175,"marketCap":30070692},{"date":"2022-03-18","current":-0.873883,"twenty":-6.590051,"median":-1.023862,"eighty":-0.266579,"marketCap":45961895},{"date":"2022-03-25","current":-0.762174,"twenty":-6.531989,"median":-1.014989,"eighty":-0.268065,"marketCap":40086545},{"date":"2022-04-01","current":-0.923727,"twenty":-6.524731,"median":-1.00028,"eighty":-0.269472,"marketCap":48583444},{"date":"2022-04-08","current":-0.850134,"twenty":-6.494485,"median":-0.985302,"eighty":-0.270029,"marketCap":44712805},{"date":"2022-04-14","current":-0.826092,"twenty":-6.489621,"median":-0.964338,"eighty":-0.270149,"marketCap":43448294},{"date":"2022-04-22","current":-0.741087,"twenty":-6.474438,"median":-0.958083,"eighty":-0.270149,"marketCap":38977467},{"date":"2022-04-29","current":-0.663171,"twenty":-6.440782,"median":-0.936443,"eighty":-0.270447,"marketCap":34879496},{"date":"2022-05-06","current":-0.627028,"twenty":-6.439062,"median":-0.931394,"eighty":-0.270685,"marketCap":32978537},{"date":"2022-05-13","current":-0.543049,"twenty":-6.423123,"median":-0.920325,"eighty":-0.271694,"marketCap":31810189},{"date":"2022-05-20","current":-0.530414,"twenty":-6.402004,"median":-0.91202,"eighty":-0.272181,"marketCap":31070055},{"date":"2022-05-27","current":-0.498227,"twenty":-6.401185,"median":-0.899185,"eighty":-0.272374,"marketCap":29184661},{"date":"2022-06-03","current":-0.458593,"twenty":-6.401185,"median":-0.886224,"eighty":-0.272396,"marketCap":26862976},{"date":"2022-06-10","current":-0.453804,"twenty":-6.382422,"median":-0.873883,"eighty":-0.272796,"marketCap":26582504},{"date":"2022-06-17","current":-0.359107,"twenty":-6.367883,"median":-0.856134,"eighty":-0.27324,"marketCap":21035393},{"date":"2022-06-24","current":-0.425608,"twenty":-6.356495,"median":-0.848371,"eighty":-0.273446,"marketCap":24930837},{"date":"2022-07-01","current":-0.409914,"twenty":-6.337521,"median":-0.841485,"eighty":-0.27357,"marketCap":24011511},{"date":"2022-07-08","current":-0.441568,"twenty":-6.327375,"median":-0.836438,"eighty":-0.273619,"marketCap":25865743},{"date":"2022-07-15","current":-0.418958,"twenty":-6.32081,"median":-0.825662,"eighty":-0.27367,"marketCap":24541292},{"date":"2022-07-22","current":-0.421618,"twenty":-6.305456,"median":-0.80419,"eighty":-0.273786,"marketCap":24697110},{"date":"2022-07-29","current":-0.341683,"twenty":-6.292255,"median":-0.800071,"eighty":-0.274141,"marketCap":20014787},{"date":"2022-08-05","current":-0.345806,"twenty":-6.292255,"median":-0.796385,"eighty":-0.274485,"marketCap":20256304},{"date":"2022-08-12","current":-0.385973,"twenty":-6.292255,"median":-0.792546,"eighty":-0.274511,"marketCap":22609152},{"date":"2022-08-19","current":-0.433519,"twenty":-6.290375,"median":-0.78519,"eighty":-0.274541,"marketCap":25394246},{"date":"2022-08-26","current":-0.534609,"twenty":-6.272404,"median":-0.77731,"eighty":-0.275089,"marketCap":28795649},{"date":"2022-09-02","current":-0.490661,"twenty":-6.264829,"median":-0.776877,"eighty":-0.27857,"marketCap":26428482},{"date":"2022-09-09","current":-0.491552,"twenty":-6.264829,"median":-0.776877,"eighty":-0.280154,"marketCap":26476446},{"date":"2022-09-16","current":-0.489771,"twenty":-6.264829,"median":-0.776877,"eighty":-0.282804,"marketCap":26380517},{"date":"2022-09-23","current":-0.37089,"twenty":-6.264829,"median":-0.776877,"eighty":-0.28796,"marketCap":19977246},{"date":"2022-09-30","current":-0.347292,"twenty":-6.264829,"median":-0.776877,"eighty":-0.291841,"marketCap":18706185},{"date":"2022-10-07","current":-0.367551,"twenty":-6.264829,"median":-0.776877,"eighty":-0.293711,"marketCap":19797378},{"date":"2022-10-14","current":-0.313231,"twenty":-6.264829,"median":-0.776877,"eighty":-0.296727,"marketCap":16871539},{"date":"2022-10-21","current":-0.322803,"twenty":-6.264829,"median":-0.776877,"eighty":-0.301028,"marketCap":17387159},{"date":"2022-10-28","current":-0.311004,"twenty":-6.264829,"median":-0.776877,"eighty":-0.303896,"marketCap":16751628},{"date":"2022-11-04","current":-0.296979,"twenty":-6.264829,"median":-0.776877,"eighty":-0.306201,"marketCap":15996186},{"date":"2022-11-11","current":-0.333935,"twenty":-6.264829,"median":-0.776877,"eighty":-0.307268,"marketCap":17986716},{"date":"2022-11-18","current":-0.343695,"twenty":-6.264829,"median":-0.776877,"eighty":-0.311138,"marketCap":18625153},{"date":"2022-11-25","current":-0.306681,"twenty":-6.264829,"median":-0.776877,"eighty":-0.314058,"marketCap":16619367},{"date":"2022-12-02","current":-0.343352,"twenty":-6.264829,"median":-0.776877,"eighty":-0.315356,"marketCap":18606580},{"date":"2022-12-09","current":-0.307063,"twenty":-6.264829,"median":-0.776877,"eighty":-0.31559,"marketCap":16640030},{"date":"2022-12-16","current":-0.294501,"twenty":-6.264829,"median":-0.776877,"eighty":-0.31612,"marketCap":15959301},{"date":"2022-12-23","current":-0.257095,"twenty":-6.264829,"median":-0.776877,"eighty":-0.31612,"marketCap":13932244},{"date":"2022-12-30","current":-0.242579,"twenty":-6.264829,"median":-0.776877,"eighty":-0.31612,"marketCap":13145624},{"date":"2023-01-06","current":-0.24565,"twenty":-6.222455,"median":-0.76702,"eighty":-0.315356,"marketCap":13312024},{"date":"2023-01-13","current":-0.26519,"twenty":-6.163975,"median":-0.749229,"eighty":-0.314573,"marketCap":14370934},{"date":"2023-01-20","current":-0.236438,"twenty":-6.134106,"median":-0.731067,"eighty":-0.31322,"marketCap":12812822},{"date":"2023-01-27","current":-0.174932,"twenty":-6.091044,"median":-0.707448,"eighty":-0.309446,"marketCap":9479751},{"date":"2023-02-03","current":-0.174932,"twenty":-5.981379,"median":-0.688946,"eighty":-0.306726,"marketCap":9479751},{"date":"2023-02-10","current":-0.149995,"twenty":-5.78444,"median":-0.678577,"eighty":-0.303344,"marketCap":8128382},{"date":"2023-02-17","current":-0.119847,"twenty":-5.711862,"median":-0.662703,"eighty":-0.300847,"marketCap":6494638},{"date":"2023-02-24","current":-0.080394,"twenty":-5.537774,"median":-0.628436,"eighty":-0.299208,"marketCap":4356651},{"date":"2023-03-03","current":-0.058435,"twenty":-5.421552,"median":-0.601303,"eighty":-0.296727,"marketCap":3166640},{"date":"2023-03-10","current":-0.043175,"twenty":-5.336928,"median":-0.591502,"eighty":-0.293919,"marketCap":2339683},{"date":"2023-03-17","current":-0.032753,"twenty":-5.271509,"median":-0.576104,"eighty":-0.29245,"marketCap":1774932},{"date":"2023-03-24","current":-0.330097,"twenty":-5.15125,"median":-0.566712,"eighty":-0.28907,"marketCap":15664431},{"date":"2023-03-31","current":-0.183306,"twenty":-5.049676,"median":-0.562474,"eighty":-0.287658,"marketCap":8698611},{"date":"2023-04-06","current":-0.16648,"twenty":-4.926247,"median":-0.556134,"eighty":-0.28293,"marketCap":7900141},{"date":"2023-04-14","current":-0.171767,"twenty":-4.826414,"median":-0.551068,"eighty":-0.281001,"marketCap":8151049},{"date":"2023-04-21","current":-0.171183,"twenty":-4.754612,"median":-0.543343,"eighty":-0.27972,"marketCap":8123324},{"date":"2023-04-28","current":-0.151903,"twenty":-4.610632,"median":-0.534662,"eighty":-0.277979,"marketCap":7208411},{"date":"2023-05-05","current":-0.155671,"twenty":-4.478042,"median":-0.530414,"eighty":-0.274544,"marketCap":7387235},{"date":"2023-05-12","current":-0.280437,"twenty":-4.308934,"median":-0.524163,"eighty":-0.273829,"marketCap":13307835},{"date":"2023-05-19","current":-0.311687,"twenty":-4.171473,"median":-0.518027,"eighty":-0.27363,"marketCap":12988001},{"date":"2023-05-26","current":-0.300316,"twenty":-4.074279,"median":-0.516309,"eighty":-0.27363,"marketCap":12514182},{"date":"2023-06-02","current":-0.261344,"twenty":-4.01456,"median":-0.513146,"eighty":-0.27357,"marketCap":10890204},{"date":"2023-06-09","current":-0.300316,"twenty":-3.925706,"median":-0.51073,"eighty":-0.273154,"marketCap":12514182},{"date":"2023-06-16","current":-0.32049,"twenty":-3.86135,"median":-0.505941,"eighty":-0.273154,"marketCap":13354829},{"date":"2023-06-23","current":-0.210726,"twenty":-3.742236,"median":-0.501033,"eighty":-0.272471,"marketCap":8780943},{"date":"2023-06-30","current":-0.228791,"twenty":-3.692602,"median":-0.498892,"eighty":-0.271724,"marketCap":9533705},{"date":"2023-07-07","current":-0.238419,"twenty":-3.661847,"median":-0.495172,"eighty":-0.270209,"marketCap":9934923},{"date":"2023-07-14","current":-0.247589,"twenty":-3.551338,"median":-0.491552,"eighty":-0.266579,"marketCap":10317035},{"date":"2023-07-21","current":-0.245847,"twenty":-3.40739,"median":-0.488071,"eighty":-0.264451,"marketCap":10244434},{"date":"2023-07-28","current":-0.277758,"twenty":-2.863834,"median":-0.484742,"eighty":-0.263662,"marketCap":11574185},{"date":"2023-08-04","current":-0.271431,"twenty":-2.67799,"median":-0.477836,"eighty":-0.263662,"marketCap":11310528},{"date":"2023-08-11","current":-0.26868,"twenty":-2.559656,"median":-0.47203,"eighty":-0.263627,"marketCap":11195894},{"date":"2023-08-18","current":-0.214984,"twenty":-2.519028,"median":-0.467141,"eighty":-0.262224,"marketCap":9556697},{"date":"2023-08-25","current":-0.179333,"twenty":-2.479084,"median":-0.464656,"eighty":-0.260807,"marketCap":7971880},{"date":"2023-09-01","current":-0.165571,"twenty":-2.430422,"median":-0.458593,"eighty":-0.258893,"marketCap":7360129},{"date":"2023-09-08","current":-0.143638,"twenty":-2.41883,"median":-0.453804,"eighty":-0.256996,"marketCap":6385151},{"date":"2023-09-15","current":-0.132457,"twenty":-2.310846,"median":-0.445425,"eighty":-0.256579,"marketCap":5888103},{"date":"2023-09-22","current":-0.125146,"twenty":-2.267653,"median":-0.438838,"eighty":-0.255586,"marketCap":5563110},{"date":"2023-09-29","current":-0.113534,"twenty":-2.239577,"median":-0.436302,"eighty":-0.254205,"marketCap":5046945},{"date":"2023-10-06","current":-0.101063,"twenty":-2.200703,"median":-0.431468,"eighty":-0.252714,"marketCap":4492546},{"date":"2023-10-13","current":-0.152239,"twenty":-2.170468,"median":-0.425542,"eighty":-0.252307,"marketCap":6767495},{"date":"2023-10-20","current":-0.151379,"twenty":-2.114316,"median":-0.421693,"eighty":-0.250918,"marketCap":6729261},{"date":"2023-10-27","current":-0.147896,"twenty":-2.032936,"median":-0.419357,"eighty":-0.249888,"marketCap":6574411},{"date":"2023-11-02","current":-0.149444,"twenty":-1.967302,"median":-0.418358,"eighty":-0.247971,"marketCap":6643233},{"date":"2023-11-10","current":-0.129446,"twenty":-1.858324,"median":-0.414303,"eighty":-0.247589,"marketCap":5754282},{"date":"2023-11-17","current":-0.175714,"twenty":-1.761881,"median":-0.409648,"eighty":-0.247381,"marketCap":6977784},{"date":"2023-11-24","current":-0.477635,"twenty":-1.688918,"median":-0.409648,"eighty":-0.247381,"marketCap":18967360},{"date":"2023-12-01","current":-0.4522,"twenty":-1.58869,"median":-0.409648,"eighty":-0.247381,"marketCap":17957324},{"date":"2023-12-08","current":-0.367461,"twenty":-1.537808,"median":-0.408897,"eighty":-0.247458,"marketCap":14592229},{"date":"2023-12-15","current":-0.212935,"twenty":-1.516939,"median":-0.402106,"eighty":-0.246971,"marketCap":8455879},{"date":"2023-12-22","current":-0.195425,"twenty":-1.515112,"median":-0.40039,"eighty":-0.24631,"marketCap":7760528},{"date":"2024-01-05","current":-0.191207,"twenty":-1.50625,"median":-0.396526,"eighty":-0.245818,"marketCap":7593034},{"date":"2024-01-12","current":-0.138549,"twenty":-1.450186,"median":-0.391544,"eighty":-0.244219,"marketCap":5501904},{"date":"2024-01-19","current":-0.134331,"twenty":-1.421553,"median":-0.388891,"eighty":-0.242591,"marketCap":5334411},{"date":"2024-01-26","current":-0.146984,"twenty":-1.400293,"median":-0.385885,"eighty":-0.240931,"marketCap":5836891},{"date":"2024-02-02","current":-0.127429,"twenty":-1.400293,"median":-0.385885,"eighty":-0.238089,"marketCap":5060331},{"date":"2024-02-09","current":-0.11337,"twenty":-1.400293,"median":-0.385885,"eighty":-0.2366,"marketCap":4502019},{"date":"2024-02-16","current":-0.104806,"twenty":-1.400293,"median":-0.385885,"eighty":-0.235101,"marketCap":4161957},{"date":"2024-02-23","current":-0.072853,"twenty":-1.400293,"median":-0.385885,"eighty":-0.233827,"marketCap":2893068},{"date":"2024-03-01","current":-0.075409,"twenty":-1.399637,"median":-0.38496,"eighty":-0.233585,"marketCap":2994579},{"date":"2024-03-08","current":-0.104423,"twenty":-1.399637,"median":-0.38496,"eighty":-0.233585,"marketCap":4146730},{"date":"2024-03-15","current":-0.114899,"twenty":-1.399637,"median":-0.38496,"eighty":-0.233585,"marketCap":4562744},{"date":"2024-03-22","current":-0.411317,"twenty":-1.399637,"median":-0.382043,"eighty":-0.233892,"marketCap":16333822},{"date":"2024-03-28","current":-0.425451,"twenty":-1.399637,"median":-0.383584,"eighty":-0.233892,"marketCap":16895102},{"date":"2024-04-05","current":-0.434334,"twenty":-1.400293,"median":-0.383133,"eighty":-0.233827,"marketCap":17938010},{"date":"2024-04-12","current":-0.718965,"twenty":-1.35332,"median":-0.383133,"eighty":-0.233827,"marketCap":29693248},{"date":"2024-04-19","current":-1.184453,"twenty":-1.317325,"median":-0.383133,"eighty":-0.233827,"marketCap":48917901},{"date":"2024-04-26","current":-1.136968,"twenty":-1.288596,"median":-0.383584,"eighty":-0.233892,"marketCap":46956765},{"date":"2024-05-03","current":-1.960935,"twenty":-1.284461,"median":-0.383584,"eighty":-0.233892,"marketCap":80986610},{"date":"2024-05-10","current":-2.06995,"twenty":-1.288596,"median":-0.383584,"eighty":-0.233892,"marketCap":85488935},{"date":"2024-05-17","current":-2.066361,"twenty":-1.347436,"median":-0.383584,"eighty":-0.233892,"marketCap":79191204},{"date":"2024-05-24","current":-0.654468,"twenty":-1.347436,"median":-0.383584,"eighty":-0.233892,"marketCap":25081821},{"date":"2024-05-31","current":-0.547302,"twenty":-1.347436,"median":-0.383584,"eighty":-0.233892,"marketCap":20974818},{"date":"2024-06-07","current":-0.486066,"twenty":-1.347436,"median":-0.383584,"eighty":-0.233892,"marketCap":18627985},{"date":"2024-06-14","current":-0.511421,"twenty":-1.349397,"median":-0.383133,"eighty":-0.233827,"marketCap":19599688},{"date":"2024-06-21","current":-0.54864,"twenty":-1.351359,"median":-0.382043,"eighty":-0.233761,"marketCap":21026081},{"date":"2024-06-28","current":-0.499014,"twenty":-1.35332,"median":-0.380954,"eighty":-0.233585,"marketCap":19124224},{"date":"2024-07-05","current":-0.482472,"twenty":-1.35332,"median":-0.380954,"eighty":-0.233585,"marketCap":18490272},{"date":"2024-07-12","current":-0.563803,"twenty":-1.35332,"median":-0.380954,"eighty":-0.233585,"marketCap":21607204},{"date":"2024-07-15","current":-0.561046,"twenty":-1.35332,"median":-0.380954,"eighty":-0.233585,"marketCap":21501545},{"date":"2024-08-02","current":-0.178169,"twenty":-1.391113,"median":-0.386838,"eighty":-0.231471,"marketCap":6828131},{"date":"2024-08-09","current":-0.166191,"twenty":-1.391113,"median":-0.386838,"eighty":-0.228719,"marketCap":6369097},{"date":"2024-08-16","current":-0.189838,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":6770752},{"date":"2024-08-23","current":-0.318699,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":11366714},{"date":"2024-08-30","current":-0.290197,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10350178},{"date":"2024-09-06","current":-0.290197,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10350178},{"date":"2024-09-13","current":-0.287606,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10257766},{"date":"2024-09-20","current":-0.287606,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10257766},{"date":"2024-09-27","current":-0.301857,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10766034},{"date":"2024-10-04","current":-0.339427,"twenty":-1.391113,"median":-0.38496,"eighty":-0.226472,"marketCap":12106012},{"date":"2024-10-11","current":-0.326472,"twenty":-1.391113,"median":-0.38496,"eighty":-0.226472,"marketCap":11643951},{"date":"2024-10-18","current":-0.318699,"twenty":-1.391113,"median":-0.38496,"eighty":-0.227855,"marketCap":11366714},{"date":"2024-10-25","current":-0.292788,"twenty":-1.391113,"median":-0.38496,"eighty":-0.227855,"marketCap":10442591},{"date":"2024-10-31","current":-0.274651,"twenty":-1.391113,"median":-0.38496,"eighty":-0.227855,"marketCap":9795704},{"date":"2024-11-08","current":-0.256514,"twenty":-1.393361,"median":-0.385885,"eighty":-0.227809,"marketCap":9148818},{"date":"2024-11-15","current":-0.254647,"twenty":-1.393361,"median":-0.385885,"eighty":-0.227809,"marketCap":9610880},{"date":"2024-11-22","current":-0.241106,"twenty":-1.393361,"median":-0.385885,"eighty":-0.229676,"marketCap":9099840},{"date":"2024-11-29","current":-0.325108,"twenty":-1.393361,"median":-0.385885,"eighty":-0.233513,"marketCap":12270219},{"date":"2024-12-06","current":-0.309071,"twenty":-1.393361,"median":-0.385885,"eighty":-0.236761,"marketCap":11664967},{"date":"2024-12-13","current":-0.30482,"twenty":-1.393361,"median":-0.385973,"eighty":-0.238275,"marketCap":11504510},{"date":"2024-12-20","current":-0.272934,"twenty":-1.393361,"median":-0.385973,"eighty":-0.239941,"marketCap":10301085},{"date":"2024-12-27","current":-0.33136,"twenty":-1.393361,"median":-0.385973,"eighty":-0.240042,"marketCap":12506185},{"date":"2025-01-03","current":-0.340738,"twenty":-1.393361,"median":-0.385973,"eighty":-0.240042,"marketCap":12860133},{"date":"2025-01-10","current":-0.340738,"twenty":-1.395609,"median":-0.386838,"eighty":-0.240017,"marketCap":12860133},{"date":"2025-01-17","current":-0.268714,"twenty":-1.395609,"median":-0.386838,"eighty":-0.240017,"marketCap":10141808},{"date":"2025-01-24","current":-0.257273,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":9709991},{"date":"2025-01-31","current":-0.281343,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":10618459},{"date":"2025-02-07","current":-0.263994,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":9963654},{"date":"2025-02-14","current":-0.267276,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":10087536},{"date":"2025-02-21","current":-0.275498,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":10397831},{"date":"2025-02-28","current":-0.179966,"twenty":-1.395609,"median":-0.385929,"eighty":-0.23843,"marketCap":6792274},{"date":"2025-03-07","current":-0.180998,"twenty":-1.397857,"median":-0.385973,"eighty":-0.237432,"marketCap":6831208},{"date":"2025-03-14","current":-0.155706,"twenty":-1.397857,"median":-0.385973,"eighty":-0.237432,"marketCap":5876641},{"date":"2025-03-21","current":-0.086349,"twenty":-1.397857,"median":-0.385973,"eighty":-0.237432,"marketCap":3258983},{"date":"2025-03-28","current":-0.074628,"twenty":-1.397857,"median":-0.385973,"eighty":-0.237059,"marketCap":2816596},{"date":"2025-04-04","current":-0.061885,"twenty":-1.397857,"median":-0.385973,"eighty":-0.2366,"marketCap":2382066},{"date":"2025-04-11","current":-0.089658,"twenty":-1.395609,"median":-0.385929,"eighty":-0.23382,"marketCap":3451100},{"date":"2025-04-17","current":-0.098261,"twenty":-1.395609,"median":-0.385929,"eighty":-0.228417,"marketCap":3782257},{"date":"2025-04-25","current":-0.141141,"twenty":-1.397857,"median":-0.385973,"eighty":-0.218296,"marketCap":5432786},{"date":"2025-05-02","current":-0.207859,"twenty":-1.397857,"median":-0.385973,"eighty":-0.215001,"marketCap":8000890},{"date":"2025-05-09","current":-0.15226,"twenty":-1.397857,"median":-0.385973,"eighty":-0.213039,"marketCap":5860803},{"date":"2025-05-16","current":-0.096312,"twenty":-1.397857,"median":-0.385973,"eighty":-0.208699,"marketCap":3707236},{"date":"2025-05-23","current":-0.144196,"twenty":-1.397857,"median":-0.385973,"eighty":-0.199939,"marketCap":5728900},{"date":"2025-05-30","current":-0.147061,"twenty":-1.397857,"median":-0.385973,"eighty":-0.194699,"marketCap":5842719},{"date":"2025-06-06","current":-0.124142,"twenty":-1.397857,"median":-0.385973,"eighty":-0.191412,"marketCap":4932166},{"date":"2025-06-13","current":-0.121914,"twenty":-1.397857,"median":-0.385973,"eighty":-0.18811,"marketCap":4843640},{"date":"2025-06-20","current":-0.088491,"twenty":-1.400105,"median":-0.386239,"eighty":-0.184618,"marketCap":3515749},{"date":"2025-06-27","current":-0.090343,"twenty":-1.400105,"median":-0.386239,"eighty":-0.182879,"marketCap":3589316},{"date":"2025-07-03","current":-0.086009,"twenty":-1.400105,"median":-0.386239,"eighty":-0.180472,"marketCap":3417135},{"date":"2025-07-11","current":-0.087676,"twenty":-1.400105,"median":-0.385929,"eighty":-0.179016,"marketCap":3483358},{"date":"2025-07-18","current":-0.077341,"twenty":-1.400105,"median":-0.382495,"eighty":-0.176152,"marketCap":3072772},{"date":"2025-07-25","current":-0.077008,"twenty":-1.400105,"median":-0.379841,"eighty":-0.173677,"marketCap":3059528},{"date":"2025-08-01","current":-0.068007,"twenty":-1.400105,"median":-0.378758,"eighty":-0.172046,"marketCap":2701920},{"date":"2025-08-08","current":-0.101191,"twenty":-1.400105,"median":-0.372049,"eighty":-0.169355,"marketCap":4020303},{"date":"2025-08-15","current":-0.0975,"twenty":-1.400105,"median":-0.370177,"eighty":-0.167882,"marketCap":3962870},{"date":"2025-08-22","current":-0.097385,"twenty":-1.400105,"median":-0.367611,"eighty":-0.166452,"marketCap":3958227},{"date":"2025-08-29","current":-0.085613,"twenty":-1.400105,"median":-0.363988,"eighty":-0.165425,"marketCap":3479760},{"date":"2025-09-05","current":-0.088289,"twenty":-1.402353,"median":-0.360171,"eighty":-0.162712,"marketCap":3588502},{"date":"2025-09-12","current":-0.108622,"twenty":-1.400105,"median":-0.358919,"eighty":-0.160467,"marketCap":4414945},{"date":"2025-09-19","current":-0.102201,"twenty":-1.400105,"median":-0.354789,"eighty":-0.156303,"marketCap":4153946},{"date":"2025-09-26","current":-0.109692,"twenty":-1.400105,"median":-0.348086,"eighty":-0.15482,"marketCap":4458424},{"date":"2025-10-03","current":-0.118253,"twenty":-1.400105,"median":-0.344152,"eighty":-0.151853,"marketCap":4806398},{"date":"2025-10-10","current":-0.123069,"twenty":-1.400105,"median":-0.34116,"eighty":-0.148969,"marketCap":5002134},{"date":"2025-10-17","current":-0.401664,"twenty":-1.400105,"median":-0.339225,"eighty":-0.148969,"marketCap":16325640},{"date":"2025-10-24","current":-0.181503,"twenty":-1.400105,"median":-0.334245,"eighty":-0.148969,"marketCap":7377170},{"date":"2025-10-31","current":-0.18059,"twenty":-1.400105,"median":-0.330503,"eighty":-0.148969,"marketCap":7340099},{"date":"2025-11-07","current":-0.155052,"twenty":-1.400105,"median":-0.328604,"eighty":-0.148969,"marketCap":6302105},{"date":"2025-11-14","current":-0.156253,"twenty":-1.400105,"median":-0.325108,"eighty":-0.148969,"marketCap":6350919},{"date":"2025-11-21","current":-0.114969,"twenty":-1.400105,"median":-0.322609,"eighty":-0.148077,"marketCap":4632435},{"date":"2025-11-28","current":-0.137272,"twenty":-1.400105,"median":-0.321982,"eighty":-0.146984,"marketCap":5531095},{"date":"2025-12-05","current":-0.111851,"twenty":-1.400105,"median":-0.321063,"eighty":-0.145119,"marketCap":4506818},{"date":"2025-12-12","current":-0.146423,"twenty":-1.400105,"median":-0.319398,"eighty":-0.143686,"marketCap":5899835},{"date":"2025-12-19","current":-0.114902,"twenty":-1.400105,"median":-0.318699,"eighty":-0.141296,"marketCap":4629732},{"date":"2025-12-26","current":-0.127241,"twenty":-1.35332,"median":-0.315919,"eighty":-0.139485,"marketCap":5126932},{"date":"2026-01-02","current":-0.104856,"twenty":-1.312132,"median":-0.315568,"eighty":-0.137341,"marketCap":4224954},{"date":"2026-01-09","current":-0.121611,"twenty":-1.253292,"median":-0.313847,"eighty":-0.135284,"marketCap":4900076},{"date":"2026-01-16","current":-0.086085,"twenty":-1.191304,"median":-0.312604,"eighty":-0.132853,"marketCap":3468619},{"date":"2026-01-23","current":-0.0822,"twenty":-1.157186,"median":-0.311756,"eighty":-0.131877,"marketCap":3312088},{"date":"2026-01-30","current":-0.07782,"twenty":-1.136834,"median":-0.310926,"eighty":-0.129452,"marketCap":3135595},{"date":"2026-02-06","current":-0.066695,"twenty":-1.108153,"median":-0.309258,"eighty":-0.12748,"marketCap":2687329}],"updateTime":1770709997066},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JAGX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606292000","title":"Jaguar Health Reduces Debt Through Equity Exchange with Iliad","url":"https://stock-news.laohu8.com/highlight/detail?id=2606292000","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606292000?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:44","pubTimestamp":1769413493,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. announced it has entered into privately negotiated exchange agreements with Iliad Research and Trading, L.P. and Streeterville, involving the exchange of outstanding royalty interests and preferred stock for pre-funded common stock purchase warrants. Specifically, Jaguar issued a pre-funded warrant to Iliad to purchase 1,553,844 shares of common stock in exchange for a $1,187,914.07 reduction in the balance of a previously issued royalty interest. Additionally, the company exchanged 22 shares of Series L Preferred Stock held by Iliad for a warrant to purchase 719,424 shares of common stock, resulting in the cancellation and retirement of those preferred shares. The transactions are intended to reduce Jaguar’s outstanding royalty and preferred stock obligations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL62kLn5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2605492213","title":"Jaguar Health highlights strategic focus on rare disease development program","url":"https://stock-news.laohu8.com/highlight/detail?id=2605492213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605492213?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:10","pubTimestamp":1769091042,"startTime":"0","endTime":"0","summary":"Jaguar Health (JAGX) provided updates regarding the company’s strategic focus on its rare disease development program for crofelemer, which is focu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jaguar-health-highlights-strategic-focus-on-rare-disease-development-program-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jaguar-health-highlights-strategic-focus-on-rare-disease-development-program-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2605849477","title":"Jaguar Health to Present Rare Disease Pipeline at Sequire Investor Summit in Puerto Rico","url":"https://stock-news.laohu8.com/highlight/detail?id=2605849477","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605849477?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:00","pubTimestamp":1769090430,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. is scheduled to present at the Sequire Investor Summit on Thursday, January 22, 2026, from 10:30 AM to 11:00 AM Eastern. The event will take place at the Condado Vanderbilt Hotel in San Juan, Puerto Rico.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on January 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL1zMgn0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2603931180","title":"BRIEF-Jaguar Health Inc - Co & Unit Entered License Agreement With Woodward Specialty Llc - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603931180","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603931180?lang=en_us&edition=fundamental","pubTime":"2026-01-16 07:11","pubTimestamp":1768518705,"startTime":"0","endTime":"0","summary":"BRIEF-Jaguar Health Inc - Co & Unit Entered License Agreement With Woodward Specialty Llc - SEC FilingJan 15  - SEC Filing:JAGUAR HEALTH INC - CO & UNIT ENTERED LICENSE AGREEMENT WITH WOODWARD SPECIALTY LLC - SEC FILINGJAGUAR HEALTH INC - WOODWARD SPECIALTY TO PAY NAPO UPFRONT $18 MILLION INCLUDING $16 MILLION ON EFFECTIVE DATE - SEC FILINGJAGUAR HEALTH INC - NAPO HAS UNILATERAL RIGHT TO REBUY RIGHTS UNDER LICENSE AGREEMENT - SEC FILINGSource text: [ID:n0001193125-26-014231]Further company coverage: JAGX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG0WY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2603093604","title":"Jaguar Health Inc - Woodward Specialty to Pay Napo Upfront $18 Mln Including $16 Mln on Effective Date - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603093604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603093604?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:08","pubTimestamp":1768514893,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG0WY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2603367099","title":"Jaguar Health Signs $38 Million U.S. Licensing Deal With Future Pak for Crofelemer Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2603367099","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603367099?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:06","pubTimestamp":1768514770,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. announced that its wholly-owned subsidiary, Napo Pharmaceuticals, has entered into a U.S. licensing agreement with an affiliate of Future Pak, LLC. Under the agreement, Future Pak will become the exclusive U.S. marketer for Mytesi , Jaguar's FDA-approved drug for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy, and Canalevia-CA1, a crofelemer prescription drug for the treatment of chemotherapy-induced diarrhea in dogs. Jaguar will receive an $18 million upfront payment—$16 million at deal closing and $2 million upon completion of post-closing conditions—as well as up to $20 million in milestone and other future payments. Jaguar will continue to manufacture both products for Future Pak. The agreement also gives Jaguar a 12-month right to reacquire the product rights under certain regulatory conditions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL9WxN7X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2603281611","title":"Jaguar Health to Present Updates at Lytham Partners Healthcare Investor Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2603281611","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603281611?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:00","pubTimestamp":1768399240,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. will present updates on near-term catalysts at the Lytham Partners Healthcare Investor Summit on Thursday, January 15, 2026. CEO Lisa Conte is scheduled to deliver the virtual presentation at 3:30 PM Eastern, with a replay available through the conference link.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on January 14, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL689wHN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2603854400","title":"Jaguar Health Secures $350,000 Unsecured Loan from Accredited Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2603854400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603854400?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:25","pubTimestamp":1768235133,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. has entered into a new financing agreement with two accredited investors, issuing $350,000 in aggregate principal amount of unsecured promissory notes. The notes bear interest at 6% per annum and mature one month after issuance. Proceeds from the transaction, which closed on January 5, 2026, will be used for working capital and general corporate purposes. The securities were offered in a private placement to accredited investors under exemptions from registration pursuant to the Securities Act of 1933.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL4Spxnj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2602954371","title":"Jaguar Health Signs $38 Million U.S. Licensing Deal with Future Pak for Mytesi and Canalevia-CA1","url":"https://stock-news.laohu8.com/highlight/detail?id=2602954371","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602954371?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:00","pubTimestamp":1768226437,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. announced that it has entered into a U.S. licensing agreement with an affiliate of Future Pak, LLC. Under the terms of the agreement, Future Pak will become the exclusive U.S. marketer for Mytesi , an FDA-approved prescription drug for noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy, and Canalevia-CA1, a prescription drug for chemotherapy-induced diarrhea in dogs. Jaguar Health will receive an upfront payment of $18 million and up to an additional $20 million in milestone and future payments. Jaguar will continue to manufacture both products. The agreement also includes provisions for Jaguar to potentially reacquire rights to the products under certain conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL2tttpJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2602116855","title":"Jaguar Animal Health Raises Short-Term Capital Through Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2602116855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602116855?lang=en_us&edition=fundamental","pubTime":"2026-01-12 19:32","pubTimestamp":1768217545,"startTime":"0","endTime":"0","summary":"Jaguar Animal Health ( ($JAGX) ) has issued an update. On January 6, 2026, Jaguar Health, Inc. entered into securities purchase agreements with two...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jaguar-animal-health-raises-short-term-capital-through-notes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jaguar-animal-health-raises-short-term-capital-through-notes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2601281899","title":"Jaguar Health Reports Crofelemer Reduces Parenteral Support in Pediatric Intestinal Failure Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2601281899","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601281899?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:01","pubTimestamp":1767708072,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. announced new results from an ongoing independent proof-of-concept study evaluating crofelemer in pediatric patients in the United Arab Emirates with intestinal failure due to short bowel syndrome  and microvillus inclusion disease . The initial results, which were presented on November 8, 2025, at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition  Annual Meeting, demonstrated reductions in parenteral support  ranging from 12 to 37 percent in treated patients. In addition, Jaguar and its subsidiary Napo Pharmaceuticals are conducting placebo-controlled clinical trials of crofelemer in adult SBS-IF patients in the EU and in pediatric MVID patients in the US, EU, and Middle East. Crofelemer has received Orphan Drug Designation from the U.S. FDA and the European Medicines Agency for both SBS and MVID.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide ac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL5y78zh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2600066819","title":"Jaguar Health Secures $240,000 FDA Grant for Canalevia-CA1 Chemotherapy-Induced Diarrhea Study in Dogs","url":"https://stock-news.laohu8.com/highlight/detail?id=2600066819","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600066819?lang=en_us&edition=fundamental","pubTime":"2026-01-02 22:00","pubTimestamp":1767362423,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. announced it has been awarded a $240,000 grant from the U.S. Food and Drug Administration's Center for Veterinary Medicine to support ongoing studies of Canalevia-CA1 for the treatment of chemotherapy-induced diarrhea  in dogs. The FDA also renewed the conditional approval of Canalevia-CA1 for a fifth and final year, effective through December 21, 2026. Jaguar Health must complete and file a successful effectiveness study to obtain full veterinary drug approval for this indication.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on January 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL1ST2wl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2591449206","title":"Jaguar Health Announces Preliminary Clinical Trial Results for Crofelemer in Short Bowel Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2591449206","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591449206?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:00","pubTimestamp":1765807254,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. has announced the submission of an abstract describing preliminary findings from a clinical trial evaluating a novel oral liquid formulation of crofelemer in adult patients with short bowel syndrome with intestinal failure . The abstract, submitted by an independent investigator at a leading SBS-IF treatment institution, is under consideration for presentation at the Digestive Disease Week conference scheduled for May 2-5, 2026. Results from the study have not yet been presented. Crofelemer has received Orphan Drug Designation from both the U.S. Food and Drug Administration and the European Medicines Agency for the treatment of SBS and microvillus inclusion disease . Jaguar Health and its subsidiary Napo Pharmaceuticals are also conducting additional clinical trials of crofelemer in both adult and pediatric patient populations with intestinal failure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL89zkft:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2591681076","title":"Jaguar Health Issues Pre-Funded Warrants in Exchange for Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2591681076","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591681076?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:47","pubTimestamp":1765576045,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. announced that it has entered into two exchange agreements with Iliad Research and Trading, L.P., resulting in the issuance of pre-funded common stock purchase warrants. Under the agreements, Jaguar Health issued a pre-funded warrant to purchase 1,304,545 shares of common stock and another pre-funded warrant to purchase additional shares, both at an exercise price of $0.001 per share. The warrants are exercisable immediately, subject to a beneficial ownership cap of 9.99%. These transactions were completed in exchange for the cancellation and retirement of 91 shares of Series M Preferred Stock previously held by Iliad. The issuance of these warrants was conducted under an exemption from registration pursuant to Section 3 of the Securities Act of 1933.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL63ww0Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2590317537","title":"Jaguar Health Showcases Novel Plant-Based Gastrointestinal Medicines in Latest Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2590317537","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590317537?lang=en_us&edition=fundamental","pubTime":"2025-12-11 03:20","pubTimestamp":1765394455,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc.  has provided updates on its ongoing efforts to develop plant-based medicines targeting gastrointestinal disorders. The company highlighted progress with its FDA-approved product Mytesi , used for symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar also noted the conditional FDA approval renewal of Canalevia-CA1 for the treatment of chemotherapy-induced diarrhea in dogs, with a confirmatory effectiveness trial expected to conclude in February 2026. Additionally, the presentation discussed the OnTarget study, emphasizing its significance as a first-of-its-kind trial and outlining next steps, including filing a final study report and completing a patient survey regarding diarrhea reduction. The company is also preparing for future studies in metastatic breast cancer patients and exploring expanded access for those not qualifying for enrollment. You can access the full presentation through the link below.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL8lxWVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2590652553","title":"Jaguar Health Inc. Held Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2590652553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590652553?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:15","pubTimestamp":1765228514,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. held a Special Meeting of Stockholders on December 8, 2025. Three proposals were submitted to stockholders and all were approved at the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL4h6hrS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2588305629","title":"Jaguar Health Seeks EMA Feedback on Canalevia EU Approval for Dog Diarrhea","url":"https://stock-news.laohu8.com/highlight/detail?id=2588305629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588305629?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:00","pubTimestamp":1764684049,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. announced that its Italian subsidiary, Napo Therapeutics S.p.A., has submitted a request to the European Medicines Agency  for scientific advice regarding the approval pathway for Canalevia  for the treatment of general diarrhea in dogs in the European Union. The request asks the EMA's Committee for Veterinary Medicinal Products  to review the company's plan and data from a completed study during a scheduled meeting in March 2026. If the EMA agrees that the updated analysis supports approval, Jaguar Health will submit a Marketing Authorization Application for Canalevia, which, if approved, would allow the product to be marketed for general diarrhea in dogs across all 27 EU member countries.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL5sH1Xb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2585460354","title":"Jaguar Health Secures Australian Patent for Crofelemer in Treating Short Bowel Syndrome and Related Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2585460354","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585460354?lang=en_us&edition=fundamental","pubTime":"2025-11-24 22:00","pubTimestamp":1763992834,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. announced that the Australian Patent Office has issued a new patent to its family company, Napo Pharmaceuticals, for methods of treating short bowel syndrome , bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal in patients using an inhibitor of chloride-ion transport such as crofelemer. The company stated that this new patent expands international intellectual property protection for crofelemer's development in short bowel syndrome with intestinal failure and supports its strategy to advance crofelemer in rare pediatric intestinal failure disorders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL5s2J8T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2584137570","title":"Jaguar Health Submits Amended Protocol to FDA for Crofelemer MVID Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2584137570","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584137570?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:00","pubTimestamp":1763647233,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. announced that it has submitted an amended protocol to the U.S. Food and Drug Administration  for its ongoing placebo-controlled clinical trial of crofelemer for the treatment of microvillus inclusion disease , a rare pediatric disorder with no approved treatments. The company took this step following feedback from an FDA meeting held on October 2, 2025, with the goal of supporting a possible expedited approval pathway for crofelemer. Jaguar Health expects that, if the study results are positive, the amended protocol could help enable a faster FDA review and approval process. No grant or funding announcement involving multiple organizations was mentioned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL1xRVCb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2584920919","title":"Jaguar Health Extends $6.2 Million Note and Amends $36 Million Royalty Agreements with Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2584920919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584920919?lang=en_us&edition=fundamental","pubTime":"2025-11-20 02:37","pubTimestamp":1763577447,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. has entered into amendments to several existing royalty interest agreements with Iliad Research and Trading, L.P., Uptown Capital, LLC, and Streeterville Capital, LLC. Under the revised terms, beginning April 1, 2026, the company will be required to make a minimum monthly royalty payment of $750,000 or the actual royalty payment amount owed, whichever is greater, to each investor. Additionally, Jaguar Health and its subsidiary, Napo Pharmaceuticals, have amended a secured promissory note with Streeterville Capital, extending its maturity date to April 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Dat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDLc2VklC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}]}}